Vyalev 12 mg/mL
foscarbidopa/foslevodopa · INJECTION · AbbVie Inc.
No Recall History
Plain English
Vyalev is a injection containing foscarbidopa/foslevodopa at 12 mg/mL, taken subcutaneous. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Vyalev
- Generic Name
- foscarbidopa/foslevodopa
- NDC Code (Product)
0074-0501- Manufacturer
- AbbVie Inc.
- Strength
- 12 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA216962
- Marketing Start
- 04/12/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Vyalev used for?
Vyalev contains foscarbidopa/foslevodopa. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Vyalev a controlled substance?
Vyalev is not classified as a controlled substance by the DEA.
What is the generic name for Vyalev?
The generic name for Vyalev is foscarbidopa/foslevodopa. There are no other listed brand versions of foscarbidopa/foslevodopa.
What is the NDC code for Vyalev 12 mg/mL?
The NDC (National Drug Code) for Vyalev 12 mg/mL is 0074-0501, listed by AbbVie Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)